バイオインフォマティクス市場- 世界の産業規模、シェア、動向、機会、予測、製品・サービス別、タイプ別、用途別、エンドユーザー別、地域別セグメント、競合、2020年～2030年

バイオインフォマティクスの世界市場規模は2024年に112億4,000万米ドル、予測期間中のCAGRは12.34%で2030年には225億9,000万米ドルに達すると予測されています。

バイオインフォマティクスは、生物学と情報技術を融合させた学際的な分野です。生物学的データと情報保存・配信・分析技術との接点を確立し、特に生物医学における様々な科学研究分野を強化します。バイオインフォマティクスは、データベース形成、データ管理、データウェアハウス、データマイニングなどの作業にソフトウェアツールを活用します。このデータマイニングは技術的発見につながり、遺伝学やゲノムの研究において重要な役割を果たしています。この市場では、タンパク質機能・解析ツール、相同性・類似性ツール、配列解析ツール、その他ツールなど、数多くのバイオインフォマティクスツールが提供されています。

Stanford Medicineが2022年1月に発表した記事によると、スタンフォード大学の科学者が行った調査により、DNA配列決定技術によりヒトゲノムの配列決定が約8時間で可能であることが示されました。このような開発により、ゲノミクス、ひいてはバイオインフォマティクス分野の需要が高まる可能性があります。バイオインフォマティクスデータストレージおよび解析アプリケーションは、老化や発がんから遺伝性疾患の予防治療まで幅広い分野の研究活動を促進するために、大量のゲノムおよびプロテオーム情報を保存することができます。この要因も、予測期間中のこの業界の成長に大きく貢献すると予想されます。

この分野は、構造ゲノミクス、機能ゲノミクス、DNAマイクロアレイ、比較ゲノミクス、医療情報など、ライフサイエンスの多様で専門的な領域を包含しています。その結果、前述のような要因が世界のバイオインフォマティクス市場の成長に寄与しています。さらに、統合ソリューションとシステムに対する需要の高まり、ヘルスケアにおける機械学習とAIの統合、ソフトウェア企業によるバイオインフォマティクスソリューションへの投資は、バイオインフォマティクスソリューション開発者に有利な市場機会を提供すると期待されています。

主な市場促進要因

核酸およびタンパク質シーケンスの需要増加

主な市場課題

データ統合のための明確な標準と共通データ形式の欠如

主な市場動向

人工知能（AI）と機械学習

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のバイオインフォマティクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品とサービス別（バイオインフォマティクスツール、バイオインフォマティクスプラットフォーム、バイオインフォマティクスサービス）
  • タイプ別（ゲノミクスとプロテオミクス、シミュレーション研究と分子モデリング、遺伝子工学、その他）
  • 用途別（メタゲノミクス、創薬、精密医療、その他）
  • エンドユーザー別（機関研究、産業研究）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のバイオインフォマティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のバイオインフォマティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のバイオインフォマティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のバイオインフォマティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのバイオインフォマティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界のバイオインフォマティクス市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• 3rd Millennium Inc.
• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• BioWisdom Ltd
• Quest Diagnostics（Celera Corporation）
• Dassault Systemes SE
• Illumina, Inc.
• Geneva Bioinformatics SA
• Perkin Elmer, Inc.
• Lineage Cell Therapeutics（BioTime Inc.）

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Bioinformatics Market was valued at USD 11.24 Billion in 2024 and is expected to reach USD 22.59 Billion by 2030 with a CAGR of 12.34% during the forecast period. Bioinformatics is an interdisciplinary field that merges biology and information technology. It establishes connections between biological data and techniques for information storage, distribution, and analysis, bolstering various areas of scientific research, particularly in biomedicine. Bioinformatics leverages software tools for tasks such as database formation, data management, data warehousing, data mining, and more. This data mining leads to technical discoveries and plays a significant role in the study of genetics and genomes. The market offers numerous bioinformatics tools, including protein functional and analysis tools, homology and similarity tools, sequence analysis tools, and miscellaneous tools.

According to an article published by Stanford Medicine in January 2022, research conducted by Stanford scientists showed that a DNA sequencing technique could sequence a human genome in about 8 hours. Such developments can boost demand for genomics and, consequently, the bioinformatics sector. Bioinformatics data storage and analysis applications are capable of storing a large amount of genomic and proteomic information to facilitate research activities in fields ranging from aging and carcinogenesis to preventive therapy for genetic diseases. This factor is also expected to significantly contribute to the growth of this industry over the forecast period.

The field encompasses diverse and specialized domains of life science, including structural genomics, functional genomics, DNA microarrays, comparative genomics, and medical information. Consequently, these aforementioned factors contribute to the growth of the global bioinformatics market. Moreover, the rising demand for integrated solutions and systems, the integration of machine learning and AI in healthcare, and the investments made by software companies in bioinformatics solutions are expected to provide lucrative market opportunities for bioinformatics solution developers.

Key Market Drivers

Increasing Demand for Nucleic Acid and Protein Sequencing

The increasing demand for nucleic acid and protein sequencing technologies is expected to have a profound impact on the field of bioinformatics, fueling a surge in demand for bioinformatics tools and expertise. Nucleic acid sequencing (such as DNA and RNA sequencing) and protein sequencing are pivotal in advancing our understanding of genetics, genomics, and proteomics, and their applications span various scientific and medical disciplines. Nucleic acid and protein sequencing generate vast amounts of raw data. As sequencing technologies become more accessible and affordable, the volume of data being generated is skyrocketing. Bioinformatics plays a critical role in managing, analyzing, and interpreting these massive datasets, driving the demand for specialized software and tools. For instance, in June 2021, the U.S. Food and Drug Administration and the Center for Drug Evaluation and Research (CDER) sanctioned 26 new molecular entities (NMEs), which will drive the growth of research and development activities.

The use of sequencing data in personalized medicine, pharmacogenomics, and disease diagnostics is growing. Bioinformatics is essential for identifying genetic variations associated with diseases, drug responses, and treatment decisions. As genomic medicine gains momentum, so does the demand for bioinformatics solutions to make sense of the genomic data.

Key Market Challenges

Lack of Well-defined Standards and Common Data Formats for Integration of Data

The lack of well-defined standards and common data formats for the integration of data is a significant challenge that can potentially restrain the demand for bioinformatics. Bioinformatics relies heavily on the integration of diverse biological and biomedical data sources, including genomics, proteomics, clinical records, and more. Biological and biomedical data are generated using various technologies and platforms, leading to differences in data formats and structures. Without standardized formats, integrating data from different sources becomes challenging and time-consuming. This can result in data incompatibility issues, making it difficult to analyze and draw meaningful conclusions.

The lack of common data standards hinders interoperability between different bioinformatics tools and databases. Researchers often need to adapt or develop custom data conversion scripts or tools to bridge data format gaps, which can lead to inefficiencies in data processing.

Converting data from one format to another can introduce errors or loss of information, particularly when dealing with large and complex datasets. These errors can have significant consequences, potentially leading to inaccurate research findings or clinical decisions. Researchers and bioinformaticians spend a substantial amount of time and effort on data preprocessing tasks, such as data format conversion and normalization. This diverts resources from actual data analysis and research, slowing down scientific progress.

Key Market Trends

Artificial Intelligence (AI) and Machine Learning

AI and machine learning techniques will be increasingly applied to analyze complex biological data. These technologies can identify patterns, predict disease risk, and optimize drug discovery processes. AI and machine learning algorithms can clean, normalize, and preprocess biological data. This includes tasks such as quality control for sequencing data, removing noise, and standardizing data formats. This ensures that the data used for analysis is of high quality. Machine learning models are excellent at recognizing patterns within biological data. This capability is crucial for identifying significant genetic variations, protein-protein interactions, and gene expression patterns associated with diseases or drug responses.

AI and machine learning play a vital role in drug discovery by predicting potential drug candidates and optimizing drug development processes. These technologies can analyze molecular structures, predict drug-target interactions, and assess the safety and efficacy of compounds.

Key Market Players

• 3rd Millennium Inc.
• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• BioWisdom Ltd
• Quest Diagnostics (Celera Corporation)
• Dassault Systemes SE
• Illumina, Inc.
• Geneva Bioinformatics SA
• Perkin Elmer, Inc.
• Lineage Cell Therapeutics (BioTime Inc.)

Report Scope:

In this report, the Global Bioinformatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioinformatics Market, By Product & Services:

• Bioinformatics Tools
• Bioinformatic Platforms
• Bioinformatic Services

Bioinformatics Market, By Type:

• Genomics & Proteomics
• Simulation Studies & Molecular Modelling
• Genetic Engineering
• Others

Bioinformatics Market, By Application:

• Metagenomics
• Drug Discovery
• Precision Medicine
• Others

Bioinformatics Market, By End User:

• Institutional Research
• Industrial Research

Bioinformatics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioinformatics Market.

Available Customizations:

Global Bioinformatics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bioinformatics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Services (Bioinformatics Tools, Bioinformatic Platforms and Bioinformatic Services)
  • 5.2.2. By Type (Genomics & Proteomics, Simulation Studies & Molecular Modelling, Genetic Engineering, Others)
  • 5.2.3. By Application (Metagenomics, Drug Discovery, Precision Medicine, Others)
  • 5.2.4. By End User (Institutional Research, Industrial Research)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Bioinformatics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Products and Services
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bioinformatics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Products and Services
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Bioinformatics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Products and Services
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Bioinformatics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Products and Services
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Bioinformatics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Products and Services
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bioinformatics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Products and Services
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Bioinformatics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Products and Services
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Bioinformatics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Products and Services
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. France Bioinformatics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Products and Services
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Bioinformatics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Products and Services
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Bioinformatics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Products and Services
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Bioinformatics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Products and Services
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Bioinformatics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Products and Services
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Bioinformatics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Products and Services
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Bioinformatics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Products and Services
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Bioinformatics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Products and Services
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Bioinformatics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Products and Services
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bioinformatics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Products and Services
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Bioinformatics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Products and Services
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Bioinformatics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Products and Services
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Bioinformatics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Products and Services
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bioinformatics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Products and Services
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Bioinformatics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Products and Services
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Bioinformatics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Products and Services
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Bioinformatics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. 3rd Millennium Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Thermo Fisher Scientific, Inc.
• 15.3. Agilent Technologies, Inc.
• 15.4. BioWisdom Ltd
• 15.5. Quest Diagnostics (Celera Corporation)
• 15.6. Dassault Systemes SE
• 15.7. Illumina, Inc.
• 15.8. Geneva Bioinformatics SA
• 15.9. Perkin Elmer, Inc.
• 15.10. Lineage Cell Therapeutics (BioTime Inc.)

16. Strategic Recommendations

17. About Us & Disclaimer